Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tandem Diabetes Care, Inc. - Common Stock (NQ: TNDM )

19.17 +0.99 (+5.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,800,299
Open 18.46
Bid (Size) 18.71 (1)
Ask (Size) 19.32 (2)
Prev. Close 18.18
Today's Range 18.39 - 19.28
52wk Range 17.64 - 53.69
Shares Outstanding 63,029,361
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
This H.B. Fuller Company Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Via Benzinga
Which stocks are experiencing notable movement on Thursday?
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements. 
Via Chartmill

Performance

YTD
-46.51%
-46.51%
1 Month
-42.81%
-42.81%
3 Month
-44.13%
-44.13%
6 Month
-56.19%
-56.19%
1 Year
-33.04%
-33.04%

More News

Read More
Which stocks are moving on Thursday?
Via Chartmill
These stocks are gapping in today's session
Via Chartmill
The Analyst Verdict: Tandem Diabetes Care In The Eyes Of 4 Experts
Via Benzinga
Earnings Scheduled For February 26, 2025
Via Benzinga
Unveiling 8 Analyst Insights On Tandem Diabetes Care
Via Benzinga
Tandem Diabetes Crashes 32% As Light Outlook Rattles Pump-Maker's Shares
Via Investor's Business Daily
Get insights into the top gainers and losers of Thursday's pre-market session.
Via Chartmill
These stocks are moving in today's after hours session
Via Chartmill
Tandem Diabetes’s (NASDAQ:TNDM) Q4 Sales Beat Estimates But Stock Drops 12.2%
Via StockStory
Topics Earnings
Exposures Financial
The Analyst Verdict: Tandem Diabetes Care In The Eyes Of 5 Experts
Via Benzinga
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes (TNDM) Q4 Earnings: What To Expect
Via StockStory
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Enters Multi-Year Research Collaboration with UVA Center for Diabetes Technology for Development of Advanced Insulin Delivery Systems
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada
From Tandem Diabetes Care, Inc.
Via Business Wire
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Via Benzinga
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Upcoming Conference Participation
From Tandem Diabetes Care, Inc.
Via Business Wire
This MINISO Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024
From Tandem Diabetes Care, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.